Titolo | Pubblicato in | Anno |
---|---|---|
Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years | CANCERS | 2024 |
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety | EXPERT OPINION ON DRUG SAFETY | 2024 |
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia | CANCERS | 2024 |
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience | FRONTIERS IN ONCOLOGY | 2022 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma